The global lentiviral vector CDMO market is set to witness a growth rate of 8% in the next 5 years. Growing demand for gene ...

Chikungunya virus disease, a debilitating mosquito-borne (Aedes spp) illness caused by an alphavirus, chikungunya virus, is usually endemic in regions with tropical climates.1 Since the beginning of ...

The rAAVrh74 viral vector is a key component in several of Sarepta’s gene therapy programs, including Elevidys, an already FDA-approved gene therapy for Duchenne muscular dystrophy.

BACKGROUND: Guided by long-term safety data for AAV5 (adeno-associated virus 5) in humans, our translational study investigated whether AAV5 effectively delivers genes to healthy and achieves ...

Lia Anthony, sister of MLB's No. 1 prospect Roman Anthony, went viral during the Boston Red Sox phenom's second-ever game and shared a behind-the-scenes look.

The FDA has designated the viral vector rAAVrh74, which Sarepta Therapeutics, Inc. (NASDAQ:SRPT) uses in its gene therapy candidate SRP-9003 for limb-girdle muscular dystrophy type 2E/R4 (LGMD2E ...

With FDA platform technology designation for its viral vector, SRPT can fast-track other therapies using the same gene-delivery method.

U.S. FDA Grants Platform Technology Designation to the Viral Vector Used in SRP-9003, Sarepta’s Investigational Gene Therapy for the Treatment of Limb Girdle Muscular Dystrophy Type 2E/R4 ...

AnelloBricks is a promising in vitro approach to producing a new class of functional viral vectors, offering dramatic advantages in manufacturing scalability and cost compared to existing vector ...

Although every viral vector comes with its own pros and cons, researchers are more frequently selecting lentiviral transduction because (1) it provides long-lasting gene expression, (2) it is ...